Mark Gurman has once more suggested a 2026 release window for the rumored iPhone Fold, adding his own not-insignificant influence to the cascade of other analysts saying the same thing. In his Sunday ...

Currently, you can pick up the iRobot Roomba Combo i5 for just $199. That's going to save you $150 off of the regular price, ...

For its next T-Mobile Tuesdays promo, the carrier announced the Wingstop deal: 3 chicken tenders, seasoned fries, and a drink ...

From concepts to real-world devices, slimmer phones are having a moment. Whether they have lasting power is another question. Abrar Al-Heeti Senior Technology Reporter Abrar Al-Heeti is a senior ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lazcluze (lazertinib) for adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and has ...

The best family cell phone plans help groups manage data usage and payments for several lines under a single account. If your family (or group of friends) wants to stick to a major carrier ...

Many older adults can enjoy the same phones as anyone else, and as such, the best phone for seniors in our testing is Apple's iPhone 16, the model that tops our guide to the best phones overall.

Below, we explain how to back up files on your phone or tablet in simple terms. Plus, we've included tips from our security experts on how to keep your data hidden from prying eyes. The default way to ...

Here are the useful, unique, and unstoppable phones and tablets for work and play: So you need a beautiful display with powerful brains? One of the fastest and most efficient SoCs just got ...

ATLANTA — In a full floor vote on Tuesday, the Georgia House of Representatives passed a ban on students having cellphones, tablets and ... students to have cell phones and other electronics ...

Tablets have longer update cycles (Apple’s iPads and Samsung’s Galaxy Tabs don’t get refreshed as frequently), meaning lower R&D costs. However, seeing as their phones are barely getting ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...